These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35932965)
41. Experimental, Thermodynamic, and Molecular Modeling Evaluation of Amorphous Simvastatin-Poly(vinylpyrrolidone) Solid Dispersions. Kapourani A; Chatzitheodoridou M; Kontogiannopoulos KN; Barmpalexis P Mol Pharm; 2020 Jul; 17(7):2703-2720. PubMed ID: 32520564 [TBL] [Abstract][Full Text] [Related]
42. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study. Chavan RB; Lodagekar A; Yadav B; Shastri NR Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174 [TBL] [Abstract][Full Text] [Related]
43. Exploring the physical stability of three nimesulide-indomethacin co-amorphous systems from the perspective of molecular aggregates. Wang M; Liu S; Jia L; Zhang J; Du S; Gong J Eur J Pharm Sci; 2020 Apr; 147():105294. PubMed ID: 32147483 [TBL] [Abstract][Full Text] [Related]
44. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions. McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097 [TBL] [Abstract][Full Text] [Related]
45. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion. Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144 [TBL] [Abstract][Full Text] [Related]
46. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
48. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability. Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843 [TBL] [Abstract][Full Text] [Related]
49. Charge-assisted bond N Qian S; Wang S; Li Z; Wang X; Ma D; Liang S; Gao Y; Zhang J; Wei Y Int J Pharm; 2017 Feb; 518(1-2):335-341. PubMed ID: 28043915 [TBL] [Abstract][Full Text] [Related]
50. Highly Soluble Glimepiride and Irbesartan Co-amorphous Formulation with Potential Application in Combination Therapy. Cruz-Angeles J; Videa M; Martínez LM AAPS PharmSciTech; 2019 Mar; 20(4):144. PubMed ID: 30887140 [TBL] [Abstract][Full Text] [Related]
51. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier. Ghanavati R; Taheri A; Homayouni A Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614 [TBL] [Abstract][Full Text] [Related]
52. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability. Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393 [TBL] [Abstract][Full Text] [Related]
53. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties. Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592 [TBL] [Abstract][Full Text] [Related]
54. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139 [TBL] [Abstract][Full Text] [Related]
55. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614 [TBL] [Abstract][Full Text] [Related]
56. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica. Yan HM; Sun E; Cui L; Jia XB; Jin X J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009 [TBL] [Abstract][Full Text] [Related]
57. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127. Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569 [TBL] [Abstract][Full Text] [Related]
58. Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. Bohr A; Nascimento TL; Harmankaya N; Weisser JJ; Wang Y; Grohganz H; Rades T; Löbmann K Molecules; 2019 Jan; 24(2):. PubMed ID: 30642009 [TBL] [Abstract][Full Text] [Related]
59. Co-amorphization of atorvastatin by lisinopril as a co-former for solubility improvement. Li W; Song J; Li J; Li M; Tian B; He Z; Liu X; Fu Q Int J Pharm; 2021 Sep; 607():120971. PubMed ID: 34363915 [TBL] [Abstract][Full Text] [Related]
60. Dissolution of amorphous nifedipine from micelle-forming carboxymethylcellulose derivatives. Bordallo E; Torneiro M; Lazzari M Carbohydr Polym; 2020 Nov; 247():116699. PubMed ID: 32829827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]